SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-171876
Filing Date
2019-06-13
Accepted
2019-06-13 08:13:31
Documents
6
Period of Report
2019-06-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d773082d8k.htm 8-K 23156
2 EX-5.1 d773082dex51.htm EX-5.1 11004
3 EX-10.1 d773082dex101.htm EX-10.1 83944
4 EX-99.1 d773082dex991.htm EX-99.1 13209
5 GRAPHIC g773082g0613080515189.jpg GRAPHIC 2771
6 GRAPHIC g773082g0613080515314.jpg GRAPHIC 1546
  Complete submission text file 0001193125-19-171876.txt   138833
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38266 | Film No.: 19894936
SIC: 2834 Pharmaceutical Preparations